| Direct Competitor Comparison | |
|---|
| CPIX | PVT1 | HSP | PVT2 | Industry |
|---|
| Market Cap: | 91.12M | N/A | 5.91B | N/A | 32.64B |
|---|
| Employees: | 106 | N/A | 16,000 | 30,3051 | 35.15k |
|---|
| Qtrly Rev Growth (yoy): | 0.00 | N/A | -0.09 | N/A | 1.74 |
|---|
| Revenue (ttm):
| 48.85M | N/A | 4.01B | 18.34B1 | 13.93B |
|---|
| Gross Margin (ttm): | 0.89 | N/A | 0.25 | N/A | 0.83 |
|---|
| EBITDA (ttm): | 11.16M | N/A | 231.40M | N/A | 5.72B |
|---|
| Operating Margin (ttm):
| 0.21 | N/A | 0.00 | N/A | 0.20 |
|---|
| Net Income (ttm): | 6.27M | N/A | -72.60M | 1.51B1 | N/A |
|---|
| EPS (ttm): | 0.33 | N/A | -0.44 | N/A | 2.00 |
|---|
| P/E (ttm): | 15.15 | N/A | N/A | N/A | 24.04 |
|---|
| PEG (5 yr expected): | 1.18 | N/A | 2.48 | N/A | 1.15 |
|---|
| P/S (ttm): | 1.87 | N/A | 1.47 | N/A | 3.04 |
|---|
|
| Pvt1 = Ben Venue Laboratories, Inc. (privately held) | | HSP = Hospira Inc. | | Pvt2 = Takeda Pharmaceutical Company Limited | | Industry = Drug Manufacturers - Other | | 1 = As of 2012 |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.63 | 0.01 | 79.22B | 17.88 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 226.85 | -0.01 | 53.85B | 36.00 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 56.30 | 0.02 | 85.88B | 31.52 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 73.54 | 0.00 | 12.65B | 31.13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.01 | 34.28B | 20.08 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 125.50 | 0.02 | 16.03B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.40 | 0.02 | 11.97B | 20.98 |
|---|
| Pfizer Inc. | PFE | 28.96 | -0.01 | 205.42B | 13.86 |
|---|
| Johnson & Johnson | JNJ | 88.09 | 0.01 | 247.43B | 23.92 |
|---|
| GlaxoSmithKline plc | GSK | 52.22 | 0.00 | 126.48B | 19.09 |
|---|
| Sanofi | SNY | 54.50 | 0.01 | 144.25B | 26.86 |
|---|
| Novartis AG | NVS | 74.15 | -0.01 | 182.20B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.13 | -0.01 | 214.26B | 21.13 |
|---|
| AstraZeneca PLC | AZN | 51.56 | -0.01 | 64.45B | 11.40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.59 | -0.01 | 57.04B | 11.15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.30 | 0.01 | 71.12B | 49.04 |
|---|
|
| News on Direct Competitors | |
|---|
Currency in USD. | |
|
0.01(0.20%) May 17, 4:00PM EDT